- Home
- HQL vs TCMD Comparison
HQL vs TCMD Comparison
Compare HQL & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQL
- TCMD
- Stock Information
- Founded
- HQL 1992
- TCMD 1995
- Country
- HQL United States
- TCMD United States
- Employees
- HQL N/A
- TCMD N/A
- Industry
- HQL Investment Managers
- TCMD Medical/Dental Instruments
- Sector
- HQL Finance
- TCMD Health Care
- Exchange
- HQL Nasdaq
- TCMD Nasdaq
- Market Cap
- HQL 374.5M
- TCMD 427.6M
- IPO Year
- HQL N/A
- TCMD 2016
- Fundamental
- Price
- HQL $13.49
- TCMD $17.00
- Analyst Decision
- HQL
- TCMD Hold
- Analyst Count
- HQL 0
- TCMD 1
- Target Price
- HQL N/A
- TCMD N/A
- AVG Volume (30 Days)
- HQL 120.9K
- TCMD 371.7K
- Earning Date
- HQL 01-01-0001
- TCMD 11-04-2024
- Dividend Yield
- HQL 11.56%
- TCMD N/A
- EPS Growth
- HQL N/A
- TCMD N/A
- EPS
- HQL 0.79
- TCMD 0.65
- Revenue
- HQL N/A
- TCMD $285,051,000.00
- Revenue This Year
- HQL N/A
- TCMD $8.83
- Revenue Next Year
- HQL N/A
- TCMD $9.86
- P/E Ratio
- HQL $17.08
- TCMD $26.31
- Revenue Growth
- HQL N/A
- TCMD 5.31
- 52 Week Low
- HQL $11.34
- TCMD $11.12
- 52 Week High
- HQL $14.37
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- HQL 36.74
- TCMD 46.03
- Support Level
- HQL $13.11
- TCMD $16.76
- Resistance Level
- HQL $13.92
- TCMD $18.40
- Average True Range (ATR)
- HQL 0.23
- TCMD 0.77
- MACD
- HQL -0.06
- TCMD -0.31
- Stochastic Oscillator
- HQL 27.94
- TCMD 9.02
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.